Kevin Brown - Concepedia

Author

Kevin Brown

Public Health England ORCID

Also Known As

Brenda Gregoline, Brown, Kevin E., CONSENSUS, Davis, Nancy, G Bath, K E Brown, K BROWN, K Brown, K E Brown, K. BROWN

423

Publications

24.9K

Citations

H-Index

182

Concepts

All Affiliations

Public Health England National Heart Lung and Blood Institute St George's, University of London National Institutes of Health University of Oxford

About

Kevin Brown is an author at Public Health England specializing in medicine, virology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	48	110	11.5K
2	Health Sciences	7	7	297
3	Arts	1	1	18
4	Education	1	1	16
5	Engineering	1	1	79

Kevin Brown

198

Publications

19.7K

Citations

H-Index

Page 1

	Year	Citations
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant Jamie Lopez Bernal, Nick Andrews, Charlotte Gower, New England Journal of Medicine	2021	3.1K
Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study Jamie Lopez Bernal, Nick Andrews, Charlotte Gower, BMJ	2021	1.4K
Erythrocyte P Antigen: Cellular Receptor for B19 Parvovirus Kevin Brown, Stacie M. Anderson, Neal S. Young Science Molecular VirologyParvovirus InfectionsPathogenesisImmunologyHematology	1993	858
COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study Victoria Hall, Sarah Foulkes, Ayoub Saei, The Lancet VaccinationPreventive MedicineVaccine DevelopmentCovid-19 Vaccine CoverageVaccine Surveillance	2021	829
SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN) Victoria Hall, Sarah Foulkes, André Charlett, The Lancet Long CovidSars-cov-2 Infection RatesCovid-19 PandemicInfection ControlAntibody-negative Health-care Workers	2021	732
Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012 A Bermingham, Meera Chand, Colin Brown, Eurosurveillance Virus EpidemiologyViral DiagnosticsRespiratory DiseasesNovel CoronavirusCovid-19 Pandemic	2012	483
Adeno-Associated Virus Serotype 4 (AAV4) and AAV5 Both Require Sialic Acid Binding for Hemagglutination and Efficient Transduction but Differ in Sialic Acid Linkage Specificity Nikola Kaludov, Kevin Brown, Robert W. Walters, Journal of Virology Molecular VirologyAav5 BindingPathogenesisImmunologyViral Pathogenesis	2001	418
Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection Jianmin Zuo, Alexander C. Dowell, Hayden Pearce, Nature Immunology Viral PersistenceAdaptive Immune SystemImmunologyT Cell ImmunityPrimary Infection	2021	418
Binding of Adeno-associated Virus Type 5 to 2,3-Linked Sialic Acid Is Required for Gene Transfer Robert W. Walters, Su Yi, Shaf Keshavjee, Journal of Biological Chemistry	2001	358
Resistance to Parvovirus B19 Infection Due to Lack of Virus Receptor (Erythrocyte P Antigen) Kevin Brown, Jonathan R. Hibbs, Giorgio Gallinella, New England Journal of Medicine	1994	352

Page 1